Clinical Trial Update: A Study to Determine the Safety and Tolerability of a Range of Doses of PeptiControl in Pre-diabetic Individuals [NA]

View source ↗

Summary

A completed clinical trial evaluating the safety and tolerability of a range of PeptiControl doses in adults with prediabetes (overweight).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overweight
• Prediabetes

Drugs mentioned

• PeptiControl

Snippet

Sponsor: Nuritas Ltd | Conditions: Pre Diabetes, Overweight | NA | Status: COMPLETED